A drug used by those with Alzheimer's to improve memory may soon provide comfort to women who suffer chronic migraines every month.

Dr. Andrew Charles of the UCLA Headache Research and Treatment Program said five percent of women have a headache more than 15 days per month and suffer from migraines three times more than men

A drug that fights mild to severe Alzheimer's disease has been approved by the Food and Drug Administration for liquid oral forms.

Forest Laboratories, Inc. announces Friday that an oral solution formulation of Namend (memantine HCl), is now available to physicians, patients, and pharmacies nationwide. Oral solution offers an alternative that may make the ingestion of Namenda easier for those patients who have trouble swallowing tablets

A drug that fights mild to severe Alzheimer's disease has been approved by the Food and Drug Administration for liquid oral forms.

Forest Laboratories, Inc. announces Friday that an oral solution formulation of Namend (memantine HCl), is now available to physicians, patients, and pharmacies nationwide. Oral solution offers an alternative that may make the ingestion of Namenda easier for those patients who have trouble swallowing tablets